Simulating COVID-19 lockdowns' impact on depressive symptoms in the northern Netherlands

模拟新冠疫情封锁对荷兰北部抑郁症状的影响

阅读:1

Abstract

BACKGROUND: During the COVID-19 (SARS-CoV-2) pandemic, a major challenge for policymakers was finding the balance between containing outbreaks and supporting mental health. Although lockdowns slowed COVID-19 transmission, it appears that they also increased the prevalence of depressive symptoms. It is not yet clear whether different, hypothetical lockdown scenarios would have differently impacted the prevalence of depressive symptoms. METHODS: To that end, we developed an open-source microsimulation model, COMMA (COvid Mental health Model with Agents). With COMMA, we explored how lock down scenarios, individual characteristics, and behaviors during lockdowns related to the prevalence of depressive symptoms during the COVID-19 period. The characteristics of the population were synthesized from Lifelines, a prospective cohort study set in the northern Netherlands. RESULTS: COMMA simulations estimated that the actual lockdown scenario between June 2020 and June 2021 would result in 10.92% (95% CI: 10.68%-11.18%) of the population experiencing depressive symptoms, up from 3.49% (95% CI: 3.49–3.49) at baseline. Had there been a full or partial lockdown for the entirety of this period, 11.44% (95% CI: 11.18%-11.69%), or 10.63% (95% CI: 10.38%-10.87%), of the population, respectively, would have experienced depressive symptoms. CONCLUSIONS: Lockdown severity was an important predictor of the prevalence of depressive symptoms, with higher rates in full lockdowns than partial lockdowns. However, across all simulations, only a minority of the population ever developed depressive symptoms. These findings suggest that lockdowns, particularly full lockdowns, are not without consequences for mental health. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-026-27001-3.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。